- Home
- TLX vs CORT Comparison
TLX vs CORT Comparison
Compare TLX & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- CORT
- Stock Information
- Founded
- TLX 2015
- CORT 1998
- Country
- TLX Australia
- CORT United States
- Employees
- TLX N/A
- CORT N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- TLX Health Care
- CORT Health Care
- Exchange
- TLX Nasdaq
- CORT Nasdaq
- Market Cap
- TLX 5.0B
- CORT 5.6B
- IPO Year
- TLX N/A
- CORT N/A
- Fundamental
- Price
- TLX $16.78
- CORT $55.31
- Analyst Decision
- TLX Strong Buy
- CORT Strong Buy
- Analyst Count
- TLX 1
- CORT 4
- Target Price
- TLX $21.00
- CORT $75.25
- AVG Volume (30 Days)
- TLX 8.7K
- CORT 791.4K
- Earning Date
- TLX 01-01-0001
- CORT 02-13-2025
- Dividend Yield
- TLX N/A
- CORT N/A
- EPS Growth
- TLX N/A
- CORT 57.97
- EPS
- TLX 0.10
- CORT 1.26
- Revenue
- TLX $430,795,970.00
- CORT $628,555,000.00
- Revenue This Year
- TLX N/A
- CORT $46.29
- Revenue Next Year
- TLX N/A
- CORT $17.09
- P/E Ratio
- TLX $168.54
- CORT $43.87
- Revenue Growth
- TLX 80.92
- CORT 39.67
- 52 Week Low
- TLX $14.01
- CORT $20.84
- 52 Week High
- TLX $19.99
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- CORT 58.22
- Support Level
- TLX N/A
- CORT $49.00
- Resistance Level
- TLX N/A
- CORT $52.17
- Average True Range (ATR)
- TLX 0.00
- CORT 1.76
- MACD
- TLX 0.00
- CORT 0.52
- Stochastic Oscillator
- TLX 0.00
- CORT 99.21
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.